Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses
This paper by Wallach and colleagues (BMJ 2020;368:l7078, doi:10.1136/bmj.l7078, published 5 February 2020) has been corrected to acknowledge discrepancies in the number of fatal adverse events…